推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-54106218，021-33363733

chinasupport@letpub.com

登录 注册 新注册优惠

Oral naltrexone maintenance treatment for opioid dependence.

S Minozzi, L Amato, S Vecchi, M Davoli… - … of systematic reviews …, 2011 - ncbi.nlm.nih.gov
... 2011 Feb 16;2:CD001333. Oral naltrexone maintenance treatment for opioid dependence. ...
2006;(1):CD001333. BACKGROUND: Research on the clinical application of oral naltrexone
agrees on several things. From a pharmacological perspective, naltrexone works. ...
All 2 versions

Gabapentin combined with naltrexone for the treatment of alcohol dependence

RF Anton, H Myrick, TM Wright… - American Journal of …, 2011 - Am Psychiatric Assoc
Objective: Naltrexone, an efficacious medication for alcohol dependence, does not work for
everyone. Symptoms such as insomnia and mood instability that are most evident during early
abstinence might respond better to a different pharmacotherapy. Gabapentin may reduce ...
Cited by 3 - Related articles - All 3 versions

Predictors for the efficacy of naltrexone treatment in alcohol dependence: sweet preference

E Laaksonen, J Lahti, JD Sinclair… - Alcohol and …, 2011 - Med Council on Alcohol
Many studies have proved the effectiveness of naltrexone in treating alcoholism. It reduces relapsing
to heavy drinking and alcohol consumption (Kranzler and Van Kirk, 2001; Laaksonen et al.,
2007; Volpicelli et al., 1992). Naltrexone efficacy was more robust among patients with ...
Cited by 2 - Related articles - All 4 versions

Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: A randomized controlled …

A DeFulio, JJ Everly, JMS Leoutsakos… - Drug and Alcohol …, 2011 - Elsevier
Naltrexone provides excellent opioid blockade, but its clinical utility is limited because
opioid-dependent patients typically refuse it. An injectable suspension of naltrexone for extended
release (XR-NTX) was recently approved by the FDA for treatment of opioid dependence. ...

WEIGHT LOSS, BLOOD PRESSURE, PULSE AND CIRCADIAN PATTERNS WITH NALTREXONE SUSTAINED-RELEASE/BUPROPION SUSTAINED-RELEASE …

J Plutzky, R Chilton, C Still… - Journal of the …, 2011 - Am Coll Cardio Found
... Cardiol. Eduardo Dunayevich Jorge Plutzky, Robert Chilton, Christopher Still, Colleen Burns,
Dennis Kim, and SUSTAINED-RELEASE COMBINATION THERAPY FOR OBESITY PATTERNS
WITH NALTREXONE SUSTAINED-RELEASE/BUPROPION WEIGHT LOSS, BLOOD ...
All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451